iRobot receives FDA approval

By Admin
Follow @AbbyPhillips89 iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 5...

 

iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 510(k) clearance by the US Food and Drug Administration (FDA) for use in hospitals. iRobot’s RP-VITA is the first autonomous navigation remote presence robot to receive FDA clearance.

Since the announcement was made, IRBT shares increased from $2.21, or 10.5%, to $23.32.

RP-VITA was developed by iRobot and InTouch Health and combines the latest in autonomous navigation and mobility technologies as well as state-of-the-art telemedicine and electronic health record integration.

In a nutshell, the robot will allow doctors to visit hospital patients remotely. They will be able to view and communicate with the patient via a high-tech iPad application.

According to iRobot, the FDA clearance states RP-VITA ‘can be used for active patient monitoring in pre-operative, peri-operative and post-surgical settings, including cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations.’

This is the first robot to be cleared for everyday use in a hospital setting, sparking a new development in the way we access and communicate with medical professionals in the future.

 

 

How do you feel about iRobot’s latest clearance? Join the discussion on Twitter @HealthCareG

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma